Astrazeneca (AZN) EBITDA (2009 - 2026)
Astrazeneca's EBITDA came in at $5.99 billion for Q3 2026, up 16.8% from $5.13 billion a year earlier and up 17.7% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Astrazeneca reported EBITDA of $21.19 billion, up 9.4% year-over-year; for FY2025, it was $19.48 billion, up 16.7% from FY2024.
- EBITDA has increased in each of the last four years, with a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
- Going back by year, EBITDA was $16.69 billion in FY2024 (+22.9%), $13.58 billion in FY2023 (+47.0%), $9.24 billion in FY2022 (+21.8%) and $7.59 billion in FY2021 (-8.7%).
- The Q3 2026 figure represents the highest quarterly EBITDA since Q4 2014.
- Year-over-year, EBITDA has increased for seven consecutive quarters, with growth averaging 14.6% over the last seven quarters.
- The fastest year-over-year change in EBITDA over five years came in Q2 2023 (growth of 96.8%), and the weakest in Q1 2022 (a decline of 18.8%).
- Business Quant data shows AZN's EBITDA at $5.09 billion (Q2 2026), $5.61 billion (Q1 2026) and $4.49 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 782.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.99 Bn |
| Jun 30, 2026 | 5.09 Bn |
| Mar 31, 2026 | 5.61 Bn |
| Dec 31, 2025 | 4.49 Bn |
| Sep 30, 2025 | 5.13 Bn |
| Jun 30, 2025 | 4.90 Bn |
| Mar 31, 2025 | 4.96 Bn |
| Dec 31, 2024 | 4.37 Bn |
| Sep 30, 2024 | 3.92 Bn |
| Jun 30, 2024 | 4.03 Bn |
| Mar 31, 2024 | 4.37 Bn |
| Jun 30, 2023 | 3.73 Bn |
| Mar 31, 2023 | 4.05 Bn |
| Jun 30, 2022 | 1.90 Bn |
| Mar 31, 2022 | 2.19 Bn |
| Dec 31, 2021 | 1.90 Bn |
| Sep 30, 2021 | 1.11 Bn |
| Jun 30, 2021 | 1.88 Bn |
| Mar 31, 2021 | 2.69 Bn |
| Dec 31, 2020 | 2.28 Bn |
API Access
Astrazeneca EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();